Document is current
Any future updates will be listed below
-
Authors
Dagnew, Alemnew F.
Hanrahan, Colleen F.
Dowdy, David W.
Martinson, Neil A.
Lebina, Limakatso
Nonyane, Bareng A. S.
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 24 February 2025
First Online: 27 February 2025
Declarations
:
: Ethical approval for the Kharitode TB trial was obtained from the Human Research Ethics Committee at the University of the Witwatersrand in South Africa (clearance number 150216). All the participants of the Kharitode TB trial (TB index patients and their contacts) provided written informed consent.The Kharitode TB trial was conducted in accordance with applicable Good Clinical Practice (GCP) guidelines and the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
